- Home
- FTAI vs HOLX Comparison
FTAI vs HOLX Comparison
Compare FTAI & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTAI
- HOLX
- Stock Information
- Founded
- FTAI 2011
- HOLX 1985
- Country
- FTAI United States
- HOLX United States
- Employees
- FTAI N/A
- HOLX N/A
- Industry
- FTAI Misc Corporate Leasing Services
- HOLX Medical Electronics
- Sector
- FTAI Industrials
- HOLX Health Care
- Exchange
- FTAI Nasdaq
- HOLX Nasdaq
- Market Cap
- FTAI 10.3B
- HOLX 12.1B
- IPO Year
- FTAI 2015
- HOLX 1990
- Fundamental
- Price
- FTAI $129.09
- HOLX $64.48
- Analyst Decision
- FTAI Strong Buy
- HOLX Hold
- Analyst Count
- FTAI 12
- HOLX 13
- Target Price
- FTAI $171.83
- HOLX $76.27
- AVG Volume (30 Days)
- FTAI 1.0M
- HOLX 3.8M
- Earning Date
- FTAI 07-22-2025
- HOLX 07-28-2025
- Dividend Yield
- FTAI 0.93%
- HOLX N/A
- EPS Growth
- FTAI N/A
- HOLX 25.36
- EPS
- FTAI 0.25
- HOLX 2.39
- Revenue
- FTAI $1,910,287,000.00
- HOLX $4,026,500,000.00
- Revenue This Year
- FTAI $35.92
- HOLX $2.99
- Revenue Next Year
- FTAI $20.27
- HOLX $4.91
- P/E Ratio
- FTAI $507.90
- HOLX $26.76
- Revenue Growth
- FTAI 58.55
- HOLX 1.66
- 52 Week Low
- FTAI $75.06
- HOLX $51.90
- 52 Week High
- FTAI $181.64
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- FTAI 62.57
- HOLX 60.95
- Support Level
- FTAI $122.00
- HOLX $63.76
- Resistance Level
- FTAI $128.98
- HOLX $65.72
- Average True Range (ATR)
- FTAI 5.01
- HOLX 1.35
- MACD
- FTAI 0.11
- HOLX -0.03
- Stochastic Oscillator
- FTAI 86.45
- HOLX 72.07
About FTAI FTAI Aviation Ltd.
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.